Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus

[1] Dorner T(2009)B cells in autoimmunity Arthritis Res Ther 11 247-210

[2] Jacobi AM(2010)Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study Arthritis Rheum 62 201-4663

[3] Lipsky PE(2010)Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis Proc Natl Acad Sci USA 107 4658-125

[4] Jacobi AM(1967)Resistance of long-lived lymphocytes and plasma cells in rat lymph nodes to treatment with prednisone, cyclophosphamide, 6-mercaptopurine, and actinomycin D J Exp Med 126 109-1112

[5] Huang W(2009)Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis J Am Soc Nephrol 20 1103-1895

[6] Wang T(2011)Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis N Engl J Med 365 1886-2089

[7] Freimuth W(2006)Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis Arthritis Res Ther 8 R182-2228

[8] Sanz I(2010)Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial Ann Rheum Dis 69 2083-1162

[9] Furie R(2005)Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis N Engl J Med 353 2219-5979

[10] Mackay M(2000)Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group N Engl J Med 343 1156-2369

[1] Dorner T(2009)B cells in autoimmunity Arthritis Res Ther 11 247-210

[2] Jacobi AM(2010)Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study Arthritis Rheum 62 201-4663

[3] Lipsky PE(2010)Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis Proc Natl Acad Sci USA 107 4658-125

[4] Jacobi AM(1967)Resistance of long-lived lymphocytes and plasma cells in rat lymph nodes to treatment with prednisone, cyclophosphamide, 6-mercaptopurine, and actinomycin D J Exp Med 126 109-1112

[5] Huang W(2009)Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis J Am Soc Nephrol 20 1103-1895

[6] Wang T(2011)Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis N Engl J Med 365 1886-2089

[7] Freimuth W(2006)Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis Arthritis Res Ther 8 R182-2228

[8] Sanz I(2010)Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial Ann Rheum Dis 69 2083-1162

[9] Furie R(2005)Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis N Engl J Med 353 2219-5979

[10] Mackay M(2000)Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group N Engl J Med 343 1156-2369